4 papers in the library · 40 citations · publishing 2018-2023
New Journal of Chemistry 2023 Bronislav Jurásek, Patrik Fagan, Bohumil Dolenský et al. 6 citations
Methoxphenidine was originally patented for its properties to treat neurotoxic injury.
International Journal of Molecular Sciences February 14, 2022 Bronislav Jurásek, Silvie Rimpelová, Martin Babor et al. 7 citations
The black market for new psychoactive substances has been constantly evolving and the substances that appear on this market cause a considerable number of issues, in extreme cases leading to human deaths. While monitoring the drug black market, we detected a sample of a dissociative anesthetic methoxphenidine, the salt of which contained an unusual anion in the form of bromo- and chloro-zincate...
Drug Testing and Analysis October 31, 2019 Kateřina Hájková, Bronislav Jurásek, Jan Čejka et al. 12 citations
Deschloroketamine (2-(methylamino)-2-phenyl-cyclohexanone) is a ketamine analog belonging to a group of dissociative anesthetics, which have been distributed within the illicit market since 2015. However, it was also being sold as 'ketamine' misleading people to believe that they were getting genuine ketamine. Dissociative anesthetics have also come to the attention of the psychiatric field due...
New Journal of Chemistry 2018 Bronislav Jurásek, František Králík, Silvie Rimpelová et al. 15 citations
Deschloroketamine has been synthesized, the absolute configuration of enantiomers elucidated and the in vitro cytotoxicity of the enantiomers determined using nine different cell lines.